Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Imaging in Biologically-Relevant Environments with AFM Using Stiff qPlus Sensors.

Pürckhauer K, Weymouth AJ, Pfeffer K, Kullmann L, Mulvihill E, Krahn MP, Müller DJ, Giessibl FJ.

Sci Rep. 2018 Jun 19;8(1):9330. doi: 10.1038/s41598-018-27608-6.

2.

Mechanism of membrane pore formation by human gasdermin-D.

Mulvihill E, Sborgi L, Mari SA, Pfreundschuh M, Hiller S, Müller DJ.

EMBO J. 2018 Jun 13. pii: e98321. doi: 10.15252/embj.201798321. [Epub ahead of print]

3.

GLP-1 Receptor Expression Within the Human Heart.

Baggio LL, Yusta B, Mulvihill EE, Cao X, Streutker CJ, Butany J, Cappola TP, Margulies KB, Drucker DJ.

Endocrinology. 2018 Apr 1;159(4):1570-1584. doi: 10.1210/en.2018-00004.

PMID:
29444223
4.
5.
6.

Inactivation of the Glucose-Dependent Insulinotropic Polypeptide Receptor Improves Outcomes following Experimental Myocardial Infarction.

Ussher JR, Campbell JE, Mulvihill EE, Baggio LL, Bates HE, McLean BA, Gopal K, Capozzi M, Yusta B, Cao X, Ali S, Kim M, Kabir MG, Seino Y, Suzuki J, Drucker DJ.

Cell Metab. 2018 Feb 6;27(2):450-460.e6. doi: 10.1016/j.cmet.2017.11.003. Epub 2017 Dec 21.

PMID:
29275960
7.

The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice.

Baggio LL, Ussher JR, McLean BA, Cao X, Kabir MG, Mulvihill EE, Mighiu AS, Zhang H, Ludwig A, Seeley RJ, Heximer SP, Drucker DJ.

Mol Metab. 2017 Nov;6(11):1339-1349. doi: 10.1016/j.molmet.2017.08.010. Epub 2017 Sep 1.

8.

Severe Short Stature in an Adolescent Male with Prader-Willi Syndrome and Congenital Adrenal Hyperplasia: A Therapeutic Conundrum.

Wasserman M, Mulvihill EM, Ganan-Soto A, Uysal S, Quintos JB.

Case Rep Endocrinol. 2017;2017:4271978. doi: 10.1155/2017/4271978. Epub 2017 May 30.

9.

Maltoporin LamB Unfolds β Hairpins along Mechanical Stress-Dependent Unfolding Pathways.

Thoma J, Ritzmann N, Wolf D, Mulvihill E, Hiller S, Müller DJ.

Structure. 2017 Jul 5;25(7):1139-1144.e2. doi: 10.1016/j.str.2017.05.010. Epub 2017 Jun 15.

PMID:
28625789
10.

Functional Investigation of Iron-Responsive Microsomal Proteins, including MirC, in Aspergillus fumigatus.

Mulvihill ED, Moloney NM, Owens RA, Dolan SK, Russell L, Doyle S.

Front Microbiol. 2017 Mar 17;8:418. doi: 10.3389/fmicb.2017.00418. eCollection 2017.

11.

Pediatric Diabetes Outpatient Center at Rhode Island Hospital: The impact of changing initial diabetes education from inpatient to outpatient.

Pingul MM, Mulvihill EM, Reinert SE, Gopalakrishnan G, Plante WA, Boney CM, Bialo SR, Quintos JB.

R I Med J (2013). 2017 Feb 1;100(2):21-24.

PMID:
28146595
12.

Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.

Mulvihill EE, Varin EM, Gladanac B, Campbell JE, Ussher JR, Baggio LL, Yusta B, Ayala J, Burmeister MA, Matthews D, Bang KWA, Ayala JE, Drucker DJ.

Cell Metab. 2017 Jan 10;25(1):152-165. doi: 10.1016/j.cmet.2016.10.007. Epub 2016 Nov 10.

13.

Unraveling the Pore-Forming Steps of Pneumolysin from Streptococcus pneumoniae.

van Pee K, Mulvihill E, Müller DJ, Yildiz Ö.

Nano Lett. 2016 Dec 14;16(12):7915-7924. Epub 2016 Nov 3.

PMID:
27796097
14.

GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death.

Sborgi L, Rühl S, Mulvihill E, Pipercevic J, Heilig R, Stahlberg H, Farady CJ, Müller DJ, Broz P, Hiller S.

EMBO J. 2016 Aug 15;35(16):1766-78. doi: 10.15252/embj.201694696. Epub 2016 Jul 14.

15.

Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis.

Mulvihill EE, Burke AC, Huff MW.

Annu Rev Nutr. 2016 Jul 17;36:275-99. doi: 10.1146/annurev-nutr-071715-050718. Epub 2016 May 4. Review.

PMID:
27146015
16.

The iron-responsive microsomal proteome of Aspergillus fumigatus.

Moloney NM, Owens RA, Meleady P, Henry M, Dolan SK, Mulvihill E, Clynes M, Doyle S.

J Proteomics. 2016 Mar 16;136:99-111. doi: 10.1016/j.jprot.2015.12.025. Epub 2015 Dec 29.

PMID:
26739764
17.

Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo.

Keire PA, Bressler SL, Mulvihill ER, Starcher BC, Kang I, Wight TN.

Matrix Biol. 2016 Mar;50:67-81. doi: 10.1016/j.matbio.2015.12.010. Epub 2015 Dec 23.

18.

Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.

Mulvihill EE, Varin EM, Ussher JR, Campbell JE, Bang KW, Abdullah T, Baggio LL, Drucker DJ.

Diabetes. 2016 Mar;65(3):742-54. doi: 10.2337/db15-1224. Epub 2015 Dec 15.

19.

TCF1 links GIPR signaling to the control of beta cell function and survival.

Campbell JE, Ussher JR, Mulvihill EE, Kolic J, Baggio LL, Cao X, Liu Y, Lamont BJ, Morii T, Streutker CJ, Tamarina N, Philipson LH, Wrana JL, MacDonald PE, Drucker DJ.

Nat Med. 2016 Jan;22(1):84-90. doi: 10.1038/nm.3997. Epub 2015 Dec 7.

PMID:
26642437
20.

Directly Observing the Lipid-Dependent Self-Assembly and Pore-Forming Mechanism of the Cytolytic Toxin Listeriolysin O.

Mulvihill E, van Pee K, Mari SA, Müller DJ, Yildiz Ö.

Nano Lett. 2015 Oct 14;15(10):6965-73. doi: 10.1021/acs.nanolett.5b02963. Epub 2015 Aug 28.

PMID:
26302195
21.

Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.

Assini JM, Mulvihill EE, Burke AC, Sutherland BG, Telford DE, Chhoker SS, Sawyez CG, Drangova M, Adams AC, Kharitonenkov A, Pin CL, Huff MW.

Endocrinology. 2015 Jun;156(6):2087-102. doi: 10.1210/en.2014-2003. Epub 2015 Mar 16.

PMID:
25774553
22.

Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors.

Mulvihill EE, Drucker DJ.

Endocr Rev. 2014 Dec;35(6):992-1019. doi: 10.1210/er.2014-1035. Epub 2014 Sep 12. Review.

PMID:
25216328
23.

Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity.

Mannini B, Mulvihill E, Sgromo C, Cascella R, Khodarahmi R, Ramazzotti M, Dobson CM, Cecchi C, Chiti F.

ACS Chem Biol. 2014 Oct 17;9(10):2309-17. doi: 10.1021/cb500505m. Epub 2014 Aug 11.

PMID:
25079908
24.

Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection.

Ussher JR, Baggio LL, Campbell JE, Mulvihill EE, Kim M, Kabir MG, Cao X, Baranek BM, Stoffers DA, Seeley RJ, Drucker DJ.

Mol Metab. 2014 May 9;3(5):507-17. doi: 10.1016/j.molmet.2014.04.009. eCollection 2014 Aug.

25.

Exploring intended infant feeding decisions among low-income women.

Gurka KK, Hornsby PP, Drake E, Mulvihill EM, Kinsey EN, Yitayew MS, Lauer C, Corriveau S, Coleman V, Gulati G, Kellams AL.

Breastfeed Med. 2014 Oct;9(8):377-84. doi: 10.1089/bfm.2014.0013. Epub 2014 Jul 9.

PMID:
25006693
26.

Multiparametric high-resolution imaging of native proteins by force-distance curve-based AFM.

Pfreundschuh M, Martinez-Martin D, Mulvihill E, Wegmann S, Muller DJ.

Nat Protoc. 2014 May;9(5):1113-30. doi: 10.1038/nprot.2014.070. Epub 2014 Apr 17.

PMID:
24743419
27.

Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ mice.

Assini JM, Mulvihill EE, Sutherland BG, Telford DE, Sawyez CG, Felder SL, Chhoker S, Edwards JY, Gros R, Huff MW.

J Lipid Res. 2013 Mar;54(3):711-24. doi: 10.1194/jlr.M032631. Epub 2012 Dec 26.

28.

Citrus flavonoids and lipid metabolism.

Assini JM, Mulvihill EE, Huff MW.

Curr Opin Lipidol. 2013 Feb;24(1):34-40. doi: 10.1097/MOL.0b013e32835c07fd. Review.

PMID:
23254473
29.

GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice.

Panjwani N, Mulvihill EE, Longuet C, Yusta B, Campbell JE, Brown TJ, Streutker C, Holland D, Cao X, Baggio LL, Drucker DJ.

Endocrinology. 2013 Jan;154(1):127-39. doi: 10.1210/en.2012-1937. Epub 2012 Nov 26.

PMID:
23183176
30.

Salt anions promote the conversion of HypF-N into amyloid-like oligomers and modulate the structure of the oligomers and the monomeric precursor state.

Campioni S, Mannini B, López-Alonso JP, Shalova IN, Penco A, Mulvihill E, Laurents DV, Relini A, Chiti F.

J Mol Biol. 2012 Dec 7;424(3-4):132-49. doi: 10.1016/j.jmb.2012.09.023. Epub 2012 Oct 3.

PMID:
23041425
31.

Citrus flavonoids and the prevention of atherosclerosis.

Mulvihill EE, Huff MW.

Cardiovasc Hematol Disord Drug Targets. 2012 Dec;12(2):84-91. Review.

PMID:
23030447
32.
33.

A molecular analysis of desiccation tolerance mechanisms in the anhydrobiotic nematode Panagrolaimus superbus using expressed sequenced tags.

Tyson T, O'Mahony Zamora G, Wong S, Skelton M, Daly B, Jones JT, Mulvihill ED, Elsworth B, Phillips M, Blaxter M, Burnell AM.

BMC Res Notes. 2012 Jan 26;5:68. doi: 10.1186/1756-0500-5-68.

34.

A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy.

Kenagy RD, Min SK, Mulvihill E, Clowes AW.

J Vasc Surg. 2011 Jul;54(1):182-191.e24. doi: 10.1016/j.jvs.2010.12.070. Epub 2011 Apr 14.

35.

Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance.

Mulvihill EE, Assini JM, Lee JK, Allister EM, Sutherland BG, Koppes JB, Sawyez CG, Edwards JY, Telford DE, Charbonneau A, St-Pierre P, Marette A, Huff MW.

Diabetes. 2011 May;60(5):1446-57. doi: 10.2337/db10-0589. Epub 2011 Apr 6.

36.

Antiatherogenic properties of flavonoids: implications for cardiovascular health.

Mulvihill EE, Huff MW.

Can J Cardiol. 2010 Mar;26 Suppl A:17A-21A. Review.

PMID:
20386755
37.

Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.

Mulvihill EE, Assini JM, Sutherland BG, DiMattia AS, Khami M, Koppes JB, Sawyez CG, Whitman SC, Huff MW.

Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):742-8. doi: 10.1161/ATVBAHA.109.201095. Epub 2010 Jan 28.

38.

Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.

Mulvihill EE, Allister EM, Sutherland BG, Telford DE, Sawyez CG, Edwards JY, Markle JM, Hegele RA, Huff MW.

Diabetes. 2009 Oct;58(10):2198-210. doi: 10.2337/db09-0634. Epub 2009 Jul 10.

39.

Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor.

Allister EM, Mulvihill EE, Barrett PH, Edwards JY, Carter LP, Huff MW.

J Lipid Res. 2008 Oct;49(10):2218-29. doi: 10.1194/jlr.M800297-JLR200. Epub 2008 Jun 27.

40.

Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.

Arendt BK, Ramirez-Alvarado M, Sikkink LA, Keats JJ, Ahmann GJ, Dispenzieri A, Fonseca R, Ketterling RP, Knudson RA, Mulvihill EM, Tschumper RC, Wu X, Zeldenrust SR, Jelinek DF.

Blood. 2008 Sep 1;112(5):1931-41. doi: 10.1182/blood-2008-03-143040. Epub 2008 Jun 20.

41.

A Marfan syndrome gene expression phenotype in cultured skin fibroblasts.

Yao Z, Jaeger JC, Ruzzo WL, Morale CZ, Emond M, Francke U, Milewicz DM, Schwartz SM, Mulvihill ER.

BMC Genomics. 2007 Sep 12;8:319.

42.

Synectin-dependent gene expression in endothelial cells.

Lanahan AA, Chittenden TW, Mulvihill E, Smith K, Schwartz S, Simons M.

Physiol Genomics. 2006 Nov 27;27(3):380-90. Epub 2006 Aug 29.

PMID:
16940428
43.

Bone morphogenetic protein 4: potential regulator of shear stress-induced graft neointimal atrophy.

Hsieh PC, Kenagy RD, Mulvihill ER, Jeanette JP, Wang X, Chang CM, Yao Z, Ruzzo WL, Justice S, Hudkins KL, Alpers CE, Berceli S, Clowes AW.

J Vasc Surg. 2006 Jan;43(1):150-8.

44.

A novel mass spectrometry-based assay for GSK-3beta activity.

Bowley E, Mulvihill E, Howard JC, Pak BJ, Gan BS, O'Gorman DB.

BMC Biochem. 2005 Dec 16;6:29.

45.

Atherosclerotic plaque smooth muscle cells have a distinct phenotype.

Mulvihill ER, Jaeger J, Sengupta R, Ruzzo WL, Reimer C, Lukito S, Schwartz SM.

Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1283-9. Epub 2004 May 13.

46.
47.

An outbreak of multiply resistant Serratia marcescens: the importance of persistent carriage.

Knowles S, Herra C, Devitt E, O'Brien A, Mulvihill E, McCann SR, Browne P, Kennedy MJ, Keane CT.

Bone Marrow Transplant. 2000 Apr;25(8):873-7.

48.

An outbreak of an unusual strain of Serratia marcescens in two Dublin hospitals.

Herra CM, Knowles SJ, Kaufmann ME, Mulvihill E, McGrath B, Keane CT.

J Hosp Infect. 1998 Jun;39(2):135-41.

PMID:
9651858
49.

The repertoire of T cell antigen receptor beta-chain variable regions associated with psoriasis vulgaris.

Moss P, Charmley P, Mulvihill E, Ziegler S, Raugi GJ, Kern D, Piepkorn M, Gelinas R.

J Invest Dermatol. 1997 Jul;109(1):14-9.

Supplemental Content

Loading ...
Support Center